Biotech Values

[DewDiligence]

GILD/ABBV/ENTA—I doubt that the “real world” difference in compliance between the two regimens will be material. Moreover, it may not be deleterious if someone on ABBV/ENTA’s 3-DAA regimen forgets to take the second daily dose of ABT-333 insofar as ABBV/ENTA have shown some compelling phase-2 data for the 2-DAA regimen of ABT-450 + ABT-267 (which are combined in a qD pill).